Immune thrombocytopenic purpura caused by immune checkpoint inhibitors for uveal malignant melanoma

Saved in:
Bibliographic Details
Published in:Journal of dermatology 2023-09, Vol.50 (9), p.e292-e294
Main Authors: Takemoto, Keita, Makino, Teruhiko, Kagoyama, Ko, Furukawa, Fumina, Mizawa, Megumi, Shimizu, Tadamichi
Format: Article
Language:English
Subjects:
Immune checkpoint inhibitors
Melanoma
Thrombocytopenic purpura
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3710-b799fb83a5111bd6cacbe40df3d5bbf51e1d3f211fce13d30e04802704e350463
cites cdi_FETCH-LOGICAL-c3710-b799fb83a5111bd6cacbe40df3d5bbf51e1d3f211fce13d30e04802704e350463
container_end_page e294
container_issue 9
container_start_page e292
container_title Journal of dermatology
container_volume 50
creator Takemoto, Keita
Makino, Teruhiko
Kagoyama, Ko
Furukawa, Fumina
Mizawa, Megumi
Shimizu, Tadamichi
description
doi_str_mv 10.1111/1346-8138.16800
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2796160435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2860255103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3710-b799fb83a5111bd6cacbe40df3d5bbf51e1d3f211fce13d30e04802704e350463</originalsourceid><addsrcrecordid>eNqFkEFP3DAQRq0KVBbac2_IEhcugXFsJ9ljRYGCkLjA2bKdSdcQx6mdFO2_r5dQDr1gjWRp5vnT-BHyjcEZy-eccVEVDePNGasagE9k9d7ZIyvgjSxKAfUBOUzpCaBcSwafyQGvgdVCihWxN97PA9JpE4M3wW6nMOLgLB3nmEtTq-eELTVb6hbSbtA-j8ENE3XDxhk3hZhoFyKd_6Duqde9-zXoPPbY6yF4_YXsd7pP-PXtPiKPV5cPFz-Lu_vrm4vvd4XlNYPC1Ot1ZxquZf6ZaSurrUEBbcdbaUwnGbKWdyVjnUXGWw4IooGyBoFcgqj4ETldcscYfs-YJuVdstjnLTDMSZX1umIVCC4zevIf-hTmOOTtVNlUUMrsiWfqfKFsDClF7NQYnddxqxionX-1s612ttWr__zi-C13Nh7bd_6f8AzIBXhxPW4_ylO3Py6X4L8idZAh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2860255103</pqid></control><display><type>article</type><title>Immune thrombocytopenic purpura caused by immune checkpoint inhibitors for uveal malignant melanoma</title><source>Wiley</source><creator>Takemoto, Keita ; Makino, Teruhiko ; Kagoyama, Ko ; Furukawa, Fumina ; Mizawa, Megumi ; Shimizu, Tadamichi</creator><creatorcontrib>Takemoto, Keita ; Makino, Teruhiko ; Kagoyama, Ko ; Furukawa, Fumina ; Mizawa, Megumi ; Shimizu, Tadamichi</creatorcontrib><identifier>ISSN: 0385-2407</identifier><identifier>ISSN: 1346-8138</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.16800</identifier><identifier>PMID: 37017454</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Immune checkpoint inhibitors ; Melanoma ; Thrombocytopenic purpura</subject><ispartof>Journal of dermatology, 2023-09, Vol.50 (9), p.e292-e294</ispartof><rights>2023 Japanese Dermatological Association.</rights><rights>Copyright © 2023 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3710-b799fb83a5111bd6cacbe40df3d5bbf51e1d3f211fce13d30e04802704e350463</citedby><cites>FETCH-LOGICAL-c3710-b799fb83a5111bd6cacbe40df3d5bbf51e1d3f211fce13d30e04802704e350463</cites><orcidid>0000-0002-6664-4525 ; 0000-0003-3348-3240 ; 0000-0002-4387-3579 ; 0000-0002-0536-1679 ; 0000-0002-3036-1451</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37017454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takemoto, Keita</creatorcontrib><creatorcontrib>Makino, Teruhiko</creatorcontrib><creatorcontrib>Kagoyama, Ko</creatorcontrib><creatorcontrib>Furukawa, Fumina</creatorcontrib><creatorcontrib>Mizawa, Megumi</creatorcontrib><creatorcontrib>Shimizu, Tadamichi</creatorcontrib><title>Immune thrombocytopenic purpura caused by immune checkpoint inhibitors for uveal malignant melanoma</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><subject>Immune checkpoint inhibitors</subject><subject>Melanoma</subject><subject>Thrombocytopenic purpura</subject><issn>0385-2407</issn><issn>1346-8138</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkEFP3DAQRq0KVBbac2_IEhcugXFsJ9ljRYGCkLjA2bKdSdcQx6mdFO2_r5dQDr1gjWRp5vnT-BHyjcEZy-eccVEVDePNGasagE9k9d7ZIyvgjSxKAfUBOUzpCaBcSwafyQGvgdVCihWxN97PA9JpE4M3wW6nMOLgLB3nmEtTq-eELTVb6hbSbtA-j8ENE3XDxhk3hZhoFyKd_6Duqde9-zXoPPbY6yF4_YXsd7pP-PXtPiKPV5cPFz-Lu_vrm4vvd4XlNYPC1Ot1ZxquZf6ZaSurrUEBbcdbaUwnGbKWdyVjnUXGWw4IooGyBoFcgqj4ETldcscYfs-YJuVdstjnLTDMSZX1umIVCC4zevIf-hTmOOTtVNlUUMrsiWfqfKFsDClF7NQYnddxqxionX-1s612ttWr__zi-C13Nh7bd_6f8AzIBXhxPW4_ylO3Py6X4L8idZAh</recordid><startdate>202309</startdate><enddate>202309</enddate><creator>Takemoto, Keita</creator><creator>Makino, Teruhiko</creator><creator>Kagoyama, Ko</creator><creator>Furukawa, Fumina</creator><creator>Mizawa, Megumi</creator><creator>Shimizu, Tadamichi</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6664-4525</orcidid><orcidid>https://orcid.org/0000-0003-3348-3240</orcidid><orcidid>https://orcid.org/0000-0002-4387-3579</orcidid><orcidid>https://orcid.org/0000-0002-0536-1679</orcidid><orcidid>https://orcid.org/0000-0002-3036-1451</orcidid></search><sort><creationdate>202309</creationdate><title>Immune thrombocytopenic purpura caused by immune checkpoint inhibitors for uveal malignant melanoma</title><author>Takemoto, Keita ; Makino, Teruhiko ; Kagoyama, Ko ; Furukawa, Fumina ; Mizawa, Megumi ; Shimizu, Tadamichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3710-b799fb83a5111bd6cacbe40df3d5bbf51e1d3f211fce13d30e04802704e350463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Immune checkpoint inhibitors</topic><topic>Melanoma</topic><topic>Thrombocytopenic purpura</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takemoto, Keita</creatorcontrib><creatorcontrib>Makino, Teruhiko</creatorcontrib><creatorcontrib>Kagoyama, Ko</creatorcontrib><creatorcontrib>Furukawa, Fumina</creatorcontrib><creatorcontrib>Mizawa, Megumi</creatorcontrib><creatorcontrib>Shimizu, Tadamichi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takemoto, Keita</au><au>Makino, Teruhiko</au><au>Kagoyama, Ko</au><au>Furukawa, Fumina</au><au>Mizawa, Megumi</au><au>Shimizu, Tadamichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune thrombocytopenic purpura caused by immune checkpoint inhibitors for uveal malignant melanoma</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2023-09</date><risdate>2023</risdate><volume>50</volume><issue>9</issue><spage>e292</spage><epage>e294</epage><pages>e292-e294</pages><issn>0385-2407</issn><issn>1346-8138</issn><eissn>1346-8138</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37017454</pmid><doi>10.1111/1346-8138.16800</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-6664-4525</orcidid><orcidid>https://orcid.org/0000-0003-3348-3240</orcidid><orcidid>https://orcid.org/0000-0002-4387-3579</orcidid><orcidid>https://orcid.org/0000-0002-0536-1679</orcidid><orcidid>https://orcid.org/0000-0002-3036-1451</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2023-09, Vol.50 (9), p.e292-e294
issn 0385-2407
1346-8138
1346-8138
language eng
recordid cdi_proquest_miscellaneous_2796160435
source Wiley
subjects Immune checkpoint inhibitors
Melanoma
Thrombocytopenic purpura
title Immune thrombocytopenic purpura caused by immune checkpoint inhibitors for uveal malignant melanoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A23%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20thrombocytopenic%20purpura%20caused%20by%20immune%20checkpoint%20inhibitors%20for%20uveal%20malignant%20melanoma&rft.jtitle=Journal%20of%20dermatology&rft.au=Takemoto,%20Keita&rft.date=2023-09&rft.volume=50&rft.issue=9&rft.spage=e292&rft.epage=e294&rft.pages=e292-e294&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.16800&rft_dat=%3Cproquest_cross%3E2860255103%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3710-b799fb83a5111bd6cacbe40df3d5bbf51e1d3f211fce13d30e04802704e350463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2860255103&rft_id=info:pmid/37017454&rfr_iscdi=true